Related Articles
Moderna ends collaboration with CRISPR company Metagenomi, parts ways with gene editing chief
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
The Mass General Brigham Heart Failure & Shock Course
This Comprehensive Mass General Brigham Heart Failure & Shock symposium will provide practical insights for all clinicians who manage patients with heart failure (HF) and…
Home-blended gastrostomy-delivered diets can supply similar nutritional intake to commercial formulas in children
Commentary on: Fraser LK, Bedendo A, O’Neill M, et al . Safety, resource use and nutritional content of home-blended diets in children who are gastrostomy…
Frontiers | Don’t be a nocebo! Why healthcare organizations should value patients’ expectations
1 MT3 Clinical Education and Consulting, Coon Rapids, MN, United States 2 Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, AB, Canada 3 Client Experience…
Exploring the dynamics of stuttering
Seeing is understanding: real-time MRI shows stuttering morphologyDr Daniela Ponssen presents the Clinical Picture study, “Visualising the dynamic morphology…
Visualising the dynamic morphology of stuttering using real-time MRI
A 42-year-old man with a history of an intermittent disorder of speech fluency beginning around the age of 4 years without any obvious triggers attended…
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials
PURPOSE Chemotherapy is established as primary treatment in patients with stage IV colorectal cancer and unresectable metastases. Data from nonrandomized clinical trials have fueled persistent…
We need to accept that radical life extension is very difficult & unlikely in foreseeable future: Venki Ramakrishnan, Nobel Prize winner
I doubt there is such a thing as ‘true’ immortality. Even if scientists were successful in slowing or even reversing aging, those interventions would not…
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications
Abstract. Biomarker-driven cancer therapy has revolutionized precision oncology. With a better understanding of tumor biology, tissue-agnostic targets have been characterized and explored, which ultimately led…
Walk the Talk Geneva 2024
The Walk the Talk: Health for All Challenge returns on Sunday 26 May 2024 to Geneva, Switzerland to provide a healthy kickstart to the Seventy-seventh…